首页> 外文期刊>Analytical chemistry >Three Dimensional Microfluidic Cell Arrays for ex Vivo Drug Screening with Mimicked Vascular Flow
【24h】

Three Dimensional Microfluidic Cell Arrays for ex Vivo Drug Screening with Mimicked Vascular Flow

机译:三维微流控细胞阵列,用于模拟血管流动的体内药物筛选

获取原文
获取原文并翻译 | 示例
       

摘要

Currently, there are no reliable ex vivo models that predict anticancer drug responses in human tumors accurately. A comprehensive method of mimicking a 3D microenvironment to study effects of anticancer drugs on specific cancer types is essential. Here, we report the development of a three-dimensional microfluidic cell array (3D μFCA), which reconstructs a 3D tumor microenvironment with cancer cells and microvascular endothelial cells. To mimic the in vivo spatial relationship between microvessels and nonendothelial cells embedded in extracellular matrix, three polydimethylsiloxane (PDMS) layers were built into this array. The multilayer property of the device enabled the imitation of the drug delivery in a microtissue array with simulated blood circulation. This 3D μFCA system may provide better predictions of drug responses and identification of a suitable treatment for a specific patient if biopsy samples are used. To the pharmaceutical industry, the scaling-up of our 3D μFCA system may offer a novel high throughput screening tool.
机译:当前,尚没有可靠的离体模型可以准确预测人肿瘤中的抗癌药物反应。模仿3D微环境以研究抗癌药对特定癌症类型的影响的全面方法至关重要。在这里,我们报告了三维微流控细胞阵列(3DμFCA)的发展,该阵列可重建具有癌细胞和微血管内皮细胞的3D肿瘤微环境。为了模拟微血管和嵌入细胞外基质的非内皮细胞之间的体内空间关系,在该阵列中构建了三个聚二甲基硅氧烷(PDMS)层。该装置的多层特性使得能够在具有模拟血液循环的微组织阵列中模仿药物的递送。如果使用活检样本,则此3DμFCA系统可以为特定患者提供更好的药物反应预测和合适治疗的识别。对于制药行业而言,我们3DμFCA系统的规模扩大可能会提供一种新颖的高通量筛选工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号